| $687M | ||
| $385M | ||
| $215M | ||
| $100M | ||
| $87M | ||
| $82M |
Buys | $0 | 0 | 0 |
Sells | $6,285,162 | 14 | 100 |
| Dayno Jeffrey M. | PRESIDENT, CEO | 0 | $0 | 1 | $774,245 | $-774,245 |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | 0 | $0 | 7 | $2.51M | $-2.51M |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | 0 | $0 | 6 | $3M | $-3M |
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
Over the last 12 months, insiders at Harmony Biosciences Holdings, Inc. have bought $0 and sold $6.29M worth of Harmony Biosciences Holdings, Inc. stock.
On average, over the past 5 years, insiders at Harmony Biosciences Holdings, Inc. have bought $0 and sold $109.9M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 7,844 shares for transaction amount of $269,049 was made by Nielsen Jack (director) on 2020‑08‑26.
| 2025-12-05 | Sale | Kapadia Sandip | CHIEF FINANCIAL OFFICER | 20,000 0.0345% | $39.54 | $790,896 | +1.86% | |
| 2025-11-21 | Sale | Kapadia Sandip | CHIEF FINANCIAL OFFICER | 3,427 0.0061% | $35.00 | $119,945 | +10.57% | |
| 2025-08-15 | Sale | Kapadia Sandip | CHIEF FINANCIAL OFFICER | 21,573 0.0371% | $36.50 | $787,378 | -11.03% | |
| 2025-04-01 | Sale | Kapadia Sandip | CHIEF FINANCIAL OFFICER | 6,987 0.0122% | $32.54 | $227,386 | +3.30% | |
| 2025-03-03 | Sale | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | 4,869 0.0086% | $32.67 | $159,090 | +4.41% | |
| 2025-01-27 | Sale | Kapadia Sandip | CHIEF FINANCIAL OFFICER | 1,775 0.0031% | $38.05 | $67,547 | -11.33% | |
| 2025-01-27 | Sale | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | 1,629 0.0029% | $38.02 | $61,941 | -11.33% | |
| 2025-01-24 | Sale | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | 13,125 0.0227% | $37.31 | $489,634 | -10.77% | |
| 2025-01-21 | Sale | Kapadia Sandip | CHIEF FINANCIAL OFFICER | 25,000 0.0435% | $40.18 | $1M | -15.97% | |
| 2025-01-21 | Sale | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | 1,123 0.0019% | $40.00 | $44,920 | -15.97% | |
| 2025-01-21 | Sale | Dayno Jeffrey M. | PRESIDENT, CEO | 19,293 0.0335% | $40.13 | $774,245 | -15.97% | |
| 2025-01-16 | Sale | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | 29,475 0.0506% | $37.41 | $1.1M | -11.78% | |
| 2025-01-15 | Sale | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | 10,507 0.0185% | $37.01 | $388,841 | -7.89% | |
| 2025-01-13 | Sale | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | 7,180 0.0128% | $37.04 | $265,946 | -6.61% | |
| 2024-11-05 | Sale | Valor IV Pharma Holdings, LLC | 10 percent owner | 600,000 0.9614% | $30.30 | $18.18M | +1.84% | |
| 2024-11-05 | Sale | Marshman Fund Trust II | 10 percent owner | 600,000 0.9614% | $30.30 | $18.18M | +1.84% | |
| 2024-11-01 | Sale | Valor IV Pharma Holdings, LLC | 10 percent owner | 4M 6.4248% | $30.30 | $121.21M | +2.93% | |
| 2024-11-01 | Sale | Marshman Fund Trust II | 10 percent owner | 4M 6.4248% | $30.30 | $121.21M | +2.93% | |
| 2024-10-29 | Sale | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | 21,496 0.0369% | $40.47 | $870,018 | -17.99% | |
| 2024-10-01 | Sale | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | 400 0.0007% | $40.19 | $16,077 | -12.58% |
| Dayno Jeffrey M. | PRESIDENT, CEO | 0 0% | $0 | 0 | 10 | |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | 0 0% | $0 | 0 | 6 | |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | 0 0% | $0 | 0 | 27 | |
| Valor IV Pharma Holdings, LLC | 10 percent owner | 6618033 11.5062% | $257.57M | 0 | 2 | |
| Marshman Fund Trust II | 10 percent owner | 6051120 10.5206% | $235.51M | 1 | 2 | <0.0001% |
| Novo Holdings A/S | 10 percent owner | 4409803 7.667% | $171.63M | 1 | 0 | <0.0001% |
| Nielsen Jack | director | 2571024 4.47% | $100.06M | 5 | 30 | <0.0001% |
| Wicki Andreas | director | 2147943 3.7344% | $83.6M | 0 | 23 | |
| Jacobs John C | PRESIDENT, CEO | 0 0% | $0 | 0 | 10 | |
| Serafin Andrew | CHIEF STRATEGY OFFICER | 0 0% | $0 | 0 | 1 |
$831,902,292 | 108 | 9.34% | $1.83B | |
$54,590,806 | 65 | 21.84% | $2.46B | |
$47,419,530 | 58 | 17.20% | $2.11B | |
$1,376,668 | 53 | 18.46% | $1.85B | |
$571,084,134 | 44 | 4.33% | $2.36B | |
$7,033,101 | 22 | -12.19% | $2.08B | |
$7,549,896 | 18 | 21.49% | $2.07B | |
$73,814,940 | 15 | -4.77% | $2.68B | |
$92,580,864 | 14 | -1.28% | $2.54B | |
$50,317,062 | 13 | -3.69% | $1.95B | |
$138,099,519 | 11 | 2.58% | $2.46B | |
$94,976,497 | 10 | -10.72% | $1.88B | |
$130,038,539 | 8 | 26.82% | $2.64B | |
$55,713,031 | 8 | -0.36% | $2.17B | |
Harmony Biosciences Holdings, Inc. (HRMY) | $25,073,947 | 7 | -5.99% | $2.24B |
$7,605,533 | 5 | 17.10% | $2.39B | |
$666,380 | 5 | -16.60% | $1.92B | |
$9,900,000 | 1 | -7.19% | $2.54B | |
$5,000,000 | 1 | -22.84% | $2.4B |
| Increased Positions | 163 | +58.21% | 5M | +10.38% |
| Decreased Positions | 117 | -41.79% | 10M | -18.83% |
| New Positions | 45 | New | 1M | New |
| Sold Out Positions | 29 | Sold Out | 855,833 | Sold Out |
| Total Postitions | 326 | +16.43% | 48M | -8.45% |
| Blackrock, Inc. | $280,570.00 | 11.94% | 6.93M | +189,003 | +2.81% | 2025-09-30 |
| Vanguard Group Inc | $206,487.00 | 8.79% | 5.1M | -13,604 | -0.27% | 2025-09-30 |
| Fmr Llc | $155,841.00 | 6.63% | 3.85M | -841,220 | -17.94% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $68,526.00 | 2.92% | 1.69M | +109,405 | +6.92% | 2025-09-30 |
| American Century Companies Inc | $67,634.00 | 2.88% | 1.67M | +168,145 | +11.2% | 2025-09-30 |
| State Street Corp | $66,987.00 | 2.85% | 1.65M | +24,358 | +1.5% | 2025-09-30 |
| Lsv Asset Management | $64,609.00 | 2.75% | 1.59M | +106,391 | +7.15% | 2025-09-30 |
| Arrowstreet Capital, Limited Partnership | $52,476.00 | 2.23% | 1.3M | +388,472 | +42.84% | 2025-09-30 |
| Valor Management Llc | $51,375.00 | 2.19% | 1.27M | -5M | -80.84% | 2025-09-30 |
| Geode Capital Management, Llc | $50,972.00 | 2.17% | 1.26M | +203,915 | +19.34% | 2025-09-30 |